GlassScriptPhysician profile
Erin L Stuck
NPI 1538831334
$825.09
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.33 · 2023: $456 · 2024: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $167.75 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $134.41 | 2023-2024 | |
| Amgen INC. | $92.91 | 2023-2024 | Repatha, Otezla, Prolia |
| Otsuka America Pharmaceutical, INC. | $74.76 | 2023-2024 | Rexulti |
| Lilly USA, LLC | $64.20 | 2023-2024 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $61.72 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $37.79 | 2023-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.74 | 2023 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $32.53 | 2024 | Voquezna |
| Pfizer INC. | $18.27 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $16.60 | 2024 | Farxiga |
| Dexcom, INC. | $16.59 | 2023 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $16.50 | 2023 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $15.71 | 2023 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $14.69 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14.33 | 2021 | |
| Glaxosmithkline, LLC. | $13.59 | 2024 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Stuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.